approval
saveDAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN) — FDA approval
April 6, 2026updated 5mo ago
community read0 votes
Sponsor: ALKEM LABS LTD. Form: TABLET, EXTENDED RELEASE. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
same company · ±60 days · 6
- approvalDAPAGLIFLOZIN: DAPAGLIFLOZIN — FDA approvalApr 6, 2026
- approvalDAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN) — FDA approvalApr 6, 2026
- approvalDAPAGLIFLOZIN: DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN) — FDA approvalApr 6, 2026
- approvalOFLOXACIN: OFLOXACIN — FDA approvalApr 8, 2026
- approvalLOSARTAN POTASSIUM: LOSARTAN POTASSIUM — FDA approvalApr 10, 2026
- approvalALDACTAZIDE: OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalApr 13, 2026
🐶 often sniffed alongside
top 8- tagApproval142 co-mentions · 71 sources
- tagSmall Molecule64 co-mentions · 64 sources
- drugHYDROCODONE BITARTRATE AND ACETAMINOPHEN28 co-mentions · 14 sources
- drugTRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN14 co-mentions · 14 sources
- drugTRAMADOL HYDROCHLORIDE14 co-mentions · 14 sources
- drugQDOLO14 co-mentions · 14 sources
- drugtramadol hydrochloride ER14 co-mentions · 14 sources
- drugLEVOCETIRIZINE DIHYDROCHLORIDE12 co-mentions · 12 sources
comments(0)
5-min edit window · permanent after that